Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

638 recalls, newest first

Class II · Moderate risk

NeoCitran

Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.

Terminated Particulate / foreign matter Novartis Consumer Health D-758-2014
Class II · Moderate risk

Theraflu

Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.

Terminated Particulate / foreign matter Novartis Consumer Health NDC 0067-6319-06 D-751-2014
Class II · Moderate risk

Belladonna Alkaloids/PB

Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.

Terminated Particulate / foreign matter Physicians Total Care, Inc. NDC 54868-0031-04 D-826-2013
Class II · Moderate risk

Cleocin Phosphate

Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.

Terminated Particulate / foreign matter Pharmacia & Upjohn LLC D-609-2013
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-24 D-887-2013
Class II · Moderate risk

Ondansetron Injection

Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot

Terminated Particulate / foreign matter Hospira, Inc. NDC 0409-4755-03 D-851-2013

Recalls by year